2m 2m 2m 2m 2m 2m 2m
Alnylam Pharma (ALNY)
NASDAQ
$227.53+$2.43 (+1.08%)
Price as of Oct 22, 2026 7:54 PM EDT- $30.1BMarket Cap
- -51.58%1-Year Change
- BiotechnologyIndustry
Alnylam Pharma (ALNY)
$227.53+$2.43 (+1.08%)
Earnings Score
Valuation | ALNY | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 1 | ||
Growth | 1 | ||
Low Earnings Volatility | 1 |
Momentum Score
Valuation | ALNY | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -7.27% | ||
12-Month Momentum | -46.91% | ||
3-Month Risk Adjusted Momentum | -20.92% | ||
12-Month Risk Adjusted Momentum | -100.36% |
True Yield
Valuation | ALNY | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | -0.41% | ||
Net Debt Paydown Yield | -0.003% |
Financial Health Score
Valuation | ALNY | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 10 |